DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

被引:22
作者
Chen, Yanmeng [1 ]
Shen, Bocun [1 ]
Zheng, Xiaochuan [1 ]
Long, Quanxin [1 ]
Xia, Jie [1 ]
Huang, Yao [1 ]
Cai, Xuefei [1 ]
Wang, Deqiang [1 ]
Chen, Juan [1 ]
Tang, Ni [1 ]
Huang, Ailong [1 ]
Hu, Yuan [1 ]
机构
[1] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Dept Infect Dis, Minist Educ,Inst Viral Hepatitis,Affiliated Hosp, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China
关键词
Hepatitis B virus; APOBEC3B; DHX9; interaction; attenuate; HEPATITIS-B-VIRUS; REPLICATION; RNA; MECHANISMS; INFECTION; MUTATION;
D O I
10.1080/22221751.2020.1725398
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the host factors involved in the process of regulating the anti-HBV function of A3B are less known. In this research, to obtain a comprehensive understanding of the interaction networks of A3B, we conducted coimmunoprecipitation and mass spectrometry to identify A3B-interacting proteins in the presence of HBV. By this approach, we determined that DExD/H-box helicase 9 (DHX9) suppressed the anti-HBV effect of A3B, and this suppression was dependent on their interaction. Although DHX9 did not affect the deamination activity of A3B in vitro assay or the viral DNA editing of A3B in HepG2-NTCP cells that support HBV infection, it inhibited the binding of A3B with pgRNA. These data suggest that DHX9 can interact with A3B and attenuate the anti-HBV efficacy of A3B.
引用
收藏
页码:366 / 377
页数:12
相关论文
共 30 条
[1]   DHX9/RHA Binding to the PBS-Segment of the Genomic RNA during HIV-1 Assembly Bolsters Virion Infectivity [J].
Boeras, Ioans ;
Song, Zhenwei ;
Moran, Andrew ;
Franklin, Jarryd ;
Brown, William Clay ;
Johnson, Marc ;
Boris-Lawrie, Kathleen ;
Heng, Xiao .
JOURNAL OF MOLECULAR BIOLOGY, 2016, 428 (11) :2418-2429
[2]   Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro [J].
Bonvin, Marianne ;
Greeve, Jobst .
JOURNAL OF GENERAL VIROLOGY, 2007, 88 :3270-3274
[3]   APOBEC3B is an enzymatic source of mutation in breast cancer [J].
Burns, Michael B. ;
Lackey, Lela ;
Carpenter, Michael A. ;
Rathore, Anurag ;
Land, Allison M. ;
Leonard, Brandon ;
Refsland, Eric W. ;
Kotandeniya, Delshanee ;
Tretyakova, Natalia ;
Nikas, Jason B. ;
Yee, Douglas ;
Temiz, Nuri I. A. ;
Donohue, Duncan E. ;
McDougle, Rebecca M. ;
Brown, William L. ;
Law, Emily K. ;
Harris, Reuben S. .
NATURE, 2013, 494 (7437) :366-370
[4]   APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription [J].
Chen, Yanmeng ;
Hu, Jie ;
Cai, Xuefei ;
Huang, Yao ;
Zhou, Xing ;
Tu, Zeng ;
Hu, Jieli ;
Tavis, John E. ;
Tang, Ni ;
Huang, Ailong ;
Hu, Yuan .
ANTIVIRAL RESEARCH, 2018, 149 :16-25
[5]   Evolutionary conflicts between viruses and restriction factors shape immunity [J].
Duggal, Nisha K. ;
Emerman, Michael .
NATURE REVIEWS IMMUNOLOGY, 2012, 12 (10) :687-695
[6]   Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences [J].
Ganem, D ;
Prince, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1118-1129
[7]   β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity [J].
Hu, Yuan ;
Cheng, Xiaohong ;
Cao, Feng ;
Huang, Ailong ;
Tavis, John E. .
ANTIVIRAL RESEARCH, 2013, 99 (03) :221-229
[8]   Nuclear factors are involved in hepatitis C virus RNA replication [J].
Isken, Olaf ;
Baroth, Martina ;
Grassmann, Claus W. ;
Weinlich, Susan ;
Ostareck, Dirk H. ;
Ostareck-Lederer, Antje ;
Behrens, Sven-Erik .
RNA, 2007, 13 (10) :1675-1692
[9]   A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1-and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx [J].
Landsberg, Christine D. ;
Megger, Dominik A. ;
Hotter, Dominik ;
Rueckborn, Meike U. ;
Eilbrecht, Mareike ;
Rashidi-Alavijeh, Jassin ;
Howe, Sebastian ;
Heinrichs, Stefan ;
Sauter, Daniel ;
Sitek, Barbara ;
Vu Thuy Khanh Le-Trilling ;
Trilling, Mirko .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[10]   The biology of DHX9 and its potential as a therapeutic target [J].
Lee, Teresa ;
Pelletier, Jerry .
ONCOTARGET, 2016, 7 (27) :42716-42739